{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T01:46:32Z","timestamp":1712108792509},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.7759\/cureus.57463","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T16:27:56Z","timestamp":1712075276000},"source":"Crossref","is-referenced-by-count":0,"title":["The Potential Role of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Reducing Pneumonia Severity in Older Adults"],"prefix":"10.7759","author":[{"given":"Heledd","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G","family":"Smithard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.09.041","article-title":"Burden of pneumonia-associated hospitalizations: United States, 2001-2014","volume":"153","author":"Hayes BH","year":"2018","unstructured":"Hayes BH, Haberling DL, Kennedy JL, Varma JK, Fry AM, Vora NM. Burden of pneumonia-associated hospitalizations: United States, 2001-2014. Chest. 2018, 153:427-37. 10.1016\/j.chest.2017.09.041","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075131","article-title":"Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study","volume":"8","author":"Millett ER","year":"2013","unstructured":"Millett ER, Quint JK, Smeeth L, Daniel RM, Thomas SL. Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS One. 2013, 8:e75131. 10.1371\/journal.pone.0075131","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4260","article-title":"Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis","volume":"345","author":"Caldeira D","year":"2012","unstructured":"Caldeira D, Alarc\u00e3o J, Vaz-Carneiro A, Costa J. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ. 2012, 345:e4260. 10.1136\/bmj.e4260","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00092507","article-title":"Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment","volume":"32","author":"Kothe H","year":"2008","unstructured":"Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J. 2008, 32:139-46. 10.1183\/09031936.00092507","journal-title":"Eur Respir J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz053","article-title":"Global and regional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis","volume":"222","author":"Shi T","year":"2020","unstructured":"Shi T, Denouel A, Tietjen AK, et al.. Global and regional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis. J Infect Dis. 2020, 222:S570-6. 10.1093\/infdis\/jiz053","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140060","article-title":"Risk factors for aspiration pneumonia in older adults","volume":"10","author":"Manabe T","year":"2015","unstructured":"Manabe T, Teramoto S, Tamiya N, Okochi J, Hizawa N. Risk factors for aspiration pneumonia in older adults. PLoS One. 2015, 10:e0140060. 10.1371\/journal.pone.0140060","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13234999","article-title":"Risk factors for community-acquired pneumonia in adults: a population-based case-control study","volume":"13","author":"Almirall J","year":"1999","unstructured":"Almirall J, Bol\u00edbar I, Balanz\u00f3 X, Gonz\u00e1lez CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999, 13:349-55. 10.1183\/09031936.99.13234999","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp09X472629","article-title":"Identification of new risk factors for pneumonia: population-based case-control study","volume":"59","author":"Vinogradova Y","year":"2009","unstructured":"Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract. 2009, 59:e329-38. 10.3399\/bjgp09X472629","journal-title":"Br J Gen Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6624.737","article-title":"Low dose beta blockade in acute stroke (\"BEST\" trial): an evaluation","volume":"296","author":"Barer DH","year":"1988","unstructured":"Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke (\"BEST\" trial): an evaluation. Br Med J (Clin Res Ed). 1988, 296:737-41. 10.1136\/bmj.296.6624.737","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200309-1219OC","article-title":"Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk","volume":"169","author":"Ohkubo T","year":"2004","unstructured":"Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med. 2004, 169:1041-5. 10.1164\/rccm.200309-1219OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai Y","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, et al.. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005, 436:112-6. 10.1038\/nature03712","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki Y","year":"2003","unstructured":"Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003, 35:881-900. 10.1016\/s1357-2725(02)00271-6","journal-title":"Int J Biochem Cell Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270920","article-title":"ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury","volume":"17","author":"Minato T","year":"2022","unstructured":"Minato T, Yamaguchi T, Hoshizaki M, et al.. ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury. PLoS One. 2022, 17:e0270920. 10.1371\/journal.pone.0270920","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng J","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, et al.. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020, 9:757-60. 10.1080\/22221751.2020.1746200","journal-title":"Emerg Microbes Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085797","article-title":"The association of cardioprotective medications with pneumonia-related outcomes","volume":"9","author":"Wu A","year":"2014","unstructured":"Wu A, Good C, Downs JR, Fine MJ, Pugh MJ, Anzueto A, Mortensen EM. The association of cardioprotective medications with pneumonia-related outcomes. PLoS One. 2014, 9:e85797. 10.1371\/journal.pone.0085797","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2018.1499293","article-title":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia","volume":"31","author":"Henry C","year":"2018","unstructured":"Henry C, Zaizafoun M, Stock E, Ghamande S, Arroliga AC, White HD. Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia. Proc (Bayl Univ Med Cent). 2018, 31:419-23. 10.1080\/08998280.2018.1499293","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes","volume":"55","author":"Mortensen EM","year":"2012","unstructured":"Mortensen EM, Nakashima B, Cornell J, et al.. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis. 2012, 55:1466-73. 10.1093\/cid\/cis733","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00115106","article-title":"ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke","volume":"29","author":"Teramoto S","year":"2007","unstructured":"Teramoto S, Yamamoto H, Yamaguchi Y, Hanaoka Y, Ishii M, Hibi S, Ouchi Y. ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke. Eur Respir J. 2007, 29:218-9; author reply 219-20. 10.1183\/09031936.00115106","journal-title":"Eur Respir J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(87)91547-9","article-title":"Angiotensin-converting enzyme and the cough reflex","volume":"2","author":"Morice AH","year":"1987","unstructured":"Morice AH, Lowry R, Brown MJ, Higenbottam T. Angiotensin-converting enzyme and the cough reflex. Lancet. 1987, 2:1116-8. 10.1016\/s0140-6736(87)91547-9","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.2.199","article-title":"Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P","volume":"51","author":"Tomaki M","year":"1996","unstructured":"Tomaki M, Ichinose M, Miura M, Hirayama Y, Kageyama N, Yamauchi H, Shirato K. Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P. Thorax. 1996, 51:199-201. 10.1136\/thx.51.2.199","journal-title":"Thorax"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nm0796-814","article-title":"Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough","volume":"2","author":"Fox AJ","year":"1996","unstructured":"Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med. 1996, 2:814-7. 10.1038\/nm0796-814","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(99)00035-7","article-title":"Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients","volume":"12","author":"Okaishi K","year":"1999","unstructured":"Okaishi K, Morimoto S, Fukuo K, Niinobu T, Hata S, Onishi T, Ogihara T. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens. 1999, 12:778-83. 10.1016\/s0895-7061(99)00035-7","journal-title":"Am J Hypertens"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00110005","article-title":"Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population","volume":"27","author":"van de Garde EM","year":"2006","unstructured":"van de Garde EM, Souverein PC, van den Bosch JM, Deneer VH, Leufkens HG. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J. 2006, 27:1217-22. 10.1183\/09031936.06.00110005","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.532","article-title":"Effectiveness of angiotensin converting enzyme inhibitors in preventing pneumonia: a systematic review and meta-analysis","volume":"23","author":"Tsunoda H","year":"2022","unstructured":"Tsunoda H, Okami Y, Honda Y, Shiroshita A, Kataoka Y, Tsujimoto Y, Matsumura K. Effectiveness of angiotensin converting enzyme inhibitors in preventing pneumonia: a systematic review and meta-analysis. J Gen Fam Med. 2022, 23:217-27. 10.1002\/jgf2.532","journal-title":"J Gen Fam Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283330948","article-title":"Antihypertensive medications and risk of community-acquired pneumonia","volume":"28","author":"Mukamal KJ","year":"2010","unstructured":"Mukamal KJ, Ghimire S, Pandey R, O'Meara ES, Gautam S. Antihypertensive medications and risk of community-acquired pneumonia. J Hypertens. 2010, 28:401-5. 10.1097\/HJH.0b013e3283330948","journal-title":"J Hypertens"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006411","article-title":"Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure","volume":"4","author":"von Haehling S","year":"2009","unstructured":"von Haehling S, Schefold JC, Jankowska E, et al.. Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure. PLoS One. 2009, 4:e6411. 10.1371\/journal.pone.0006411","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2000.1148","article-title":"Modulation of neutrophil migration and superoxide anion release by metoprolol","volume":"32","author":"Dunzendorfer S","year":"2000","unstructured":"Dunzendorfer S, Wiedermann CJ. Modulation of neutrophil migration and superoxide anion release by metoprolol. J Mol Cell Cardiol. 2000, 32:915-24. 10.1006\/jmcc.2000.1148","journal-title":"J Mol Cell Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1999.00407.x","article-title":"Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells","volume":"29","author":"Garlichs CD","year":"1999","unstructured":"Garlichs CD, Zhang H, M\u00fcgge A, Daniel WG. Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells. Eur J Clin Invest. 1999, 29:12-6. 10.1046\/j.1365-2362.1999.00407.x","journal-title":"Eur J Clin Invest"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.1.30","article-title":"Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease","volume":"56","author":"Roland M","year":"2001","unstructured":"Roland M, Bhowmik A, Sapsford RJ, Seemungal TA, Jeffries DJ, Warner TD, Wedzicha JA. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax. 2001, 56:30-5. 10.1136\/thorax.56.1.30","journal-title":"Thorax"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/imj.13377","article-title":"Triggering of acute myocardial infarction by respiratory infection","volume":"47","author":"Ruane L","year":"2017","unstructured":"Ruane L, Buckley T, Hoo SY, et al.. Triggering of acute myocardial infarction by respiratory infection. Intern Med J. 2017, 47:522-9. 10.1111\/imj.13377","journal-title":"Intern Med J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.1.51","article-title":"Circulating interleukin 6 and interleukin 10 in community acquired pneumonia","volume":"54","author":"Glynn P","year":"1999","unstructured":"Glynn P, Coakley R, Kilgallen I, Murphy N, O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax. 1999, 54:51-5. 10.1136\/thx.54.1.51","journal-title":"Thorax"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.10.5.813-820.2003","article-title":"Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia","volume":"10","author":"Fern\u00e1ndez-Serrano S","year":"2003","unstructured":"Fern\u00e1ndez-Serrano S, Dorca J, Coromines M, Carratal\u00e0 J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol. 2003, 10:813-20. 10.1128\/cdli.10.5.813-820.2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.008260","article-title":"\u03b2-Blockers, pneumonia, and outcome after ischemic stroke: evidence from virtual international stroke trials archive","volume":"46","author":"Sykora M","year":"2015","unstructured":"Sykora M, Siarnik P, Diedler J. \u03b2-Blockers, pneumonia, and outcome after ischemic stroke: evidence from virtual international stroke trials archive. Stroke. 2015, 46:1269-74. 10.1161\/STROKEAHA.114.008260","journal-title":"Stroke"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13397","article-title":"Increased levels of substance P in patients taking beta-blockers are linked with a protective effect on oropharyngeal dysphagia","volume":"30","author":"Miarons M","year":"2018","unstructured":"Miarons M, Tomsen N, Nascimento W, Esp\u00edn \u00c0, L\u00f3pez-Faix\u00f3 D, Clav\u00e9 P, Rofes L. Increased levels of substance P in patients taking beta-blockers are linked with a protective effect on oropharyngeal dysphagia. Neurogastroenterol Motil. 2018, 30:e13397. 10.1111\/nmo.13397","journal-title":"Neurogastroenterol Motil"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.4.479","article-title":"Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study","volume":"26","author":"Etminan M","year":"2006","unstructured":"Etminan M, Zhang B, Fitzgerald M, Brophy JM. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study. Pharmacotherapy. 2006, 26:479-82. 10.1592\/phco.26.4.479","journal-title":"Pharmacotherapy"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196174","article-title":"Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression","volume":"13","author":"Maier IL","year":"2018","unstructured":"Maier IL, Becker JC, Leyhe JR, Schnieder M, Behme D, Psychogios MN, Liman J. Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression. PLoS One. 2018, 13:e0196174. 10.1371\/journal.pone.0196174","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S400420","article-title":"Incidence and predictors of aspiration pneumonia among stroke patients in Western Amhara region, North-West Ethiopia: a retrospective follow up study","volume":"16","author":"Lidetu T","year":"2023","unstructured":"Lidetu T, Muluneh EK, Wassie GT. Incidence and predictors of aspiration pneumonia among stroke patients in Western Amhara region, North-West Ethiopia: a retrospective follow up study. Int J Gen Med. 2023, 16:1303-15. 10.2147\/IJGM.S400420","journal-title":"Int J Gen Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)76506-5","article-title":"ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives","volume":"353","author":"Teramoto S","year":"1999","unstructured":"Teramoto S, Ouchi Y. ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives. Lancet. 1999, 353:843. 10.1016\/S0140-6736(05)76506-5","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.1996","article-title":"Mortality, morbidity, and disease severity of patients with aspiration pneumonia","volume":"8","author":"Lanspa MJ","year":"2013","unstructured":"Lanspa MJ, Jones BE, Brown SM, Dean NC. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med. 2013, 8:83-90. 10.1002\/jhm.1996","journal-title":"J Hosp Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"K\u00f8ber L","year":"1995","unstructured":"K\u00f8ber L, Torp-Pedersen C, Carlsen JE, et al.. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med. 1995, 333:1670-6. 10.1056\/NEJM199512213332503","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/BF00192366","article-title":"Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure","volume":"49","author":"Widimsk\u00fd J","year":"1995","unstructured":"Widimsk\u00fd J, Kremer HJ, Jerie P, Uhl\u00edr O. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure. Eur J Clin Pharmacol. 1995, 49:95-102. 10.1007\/BF00192366","journal-title":"Eur J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.9.1059","article-title":"Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study","volume":"162","author":"Mortensen EM","year":"2002","unstructured":"Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 2002, 162:1059-64. 10.1001\/archinte.162.9.1059","journal-title":"Arch Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60114-6","article-title":"ACE inhibitors and pneumonia","volume":"352","author":"Sekizawa K","year":"1998","unstructured":"Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet. 1998, 352:1069. 10.1016\/S0140-6736(05)60114-6","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.10.007","article-title":"Beta-blockers reduce the risk of early death in ischemic stroke","volume":"252","author":"Dziedzic T","year":"2007","unstructured":"Dziedzic T, Slowik A, Pera J, Szczudlik A. Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci. 2007, 252:53-6. 10.1016\/j.jns.2006.10.007","journal-title":"J Neurol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.2.660","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke","volume":"119","author":"Arai T","year":"2001","unstructured":"Arai T, Yasuda Y, Takaya T, et al.. Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke. Chest. 2001, 119:660-1. 10.1378\/chest.119.2.660","journal-title":"Chest"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000150897.14961.0F","article-title":"ACE inhibitors and protection against pneumonia in elderly patients with stroke","volume":"64","author":"Arai T","year":"2005","unstructured":"Arai T, Sekizawa K, Ohrui T, Fujiwara H, Yoshimi N, Matsuoka H, Sasaki H. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology. 2005, 64:573-4. 10.1212\/01.WNL.0000150897.14961.0F","journal-title":"Neurology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2012.08.006","article-title":"Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality","volume":"23","author":"Bosch X","year":"2012","unstructured":"Bosch X, Formiga F, Cuerpo S, Torres B, Ros\u00f3n B, L\u00f3pez-Soto A. Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality. Eur J Intern Med. 2012, 23:720-6. 10.1016\/j.ejim.2012.08.006","journal-title":"Eur J Intern Med"},{"key":"ref48","article-title":"Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo","volume":"53","author":"Kohm AP","year":"2001","unstructured":"Kohm AP, Sanders VM. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001, 53:487-525.","journal-title":"Pharmacol Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2018.06.017","article-title":"Performance of the CURB-65 score in predicting critical care interventions in patients admitted with community-acquired pneumonia","volume":"74","author":"Ilg A","year":"2019","unstructured":"Ilg A, Moskowitz A, Konanki V, Patel PV, Chase M, Grossestreuer AV, Donnino MW. Performance of the CURB-65 score in predicting critical care interventions in patients admitted with community-acquired pneumonia. Ann Emerg Med. 2019, 74:60-8. 10.1016\/j.annemergmed.2018.06.017","journal-title":"Ann Emerg Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afh234","article-title":"The CURB (confusion, urea, respiratory rate and blood pressure) criteria in community-acquired pneumonia (CAP) in hospitalised elderly patients aged 65 years and over: a prospective observational cohort study","volume":"34","author":"Myint PK","year":"2005","unstructured":"Myint PK, Kamath AV, Vowler SL, Maisey DN, Harrison BD. The CURB (confusion, urea, respiratory rate and blood pressure) criteria in community-acquired pneumonia (CAP) in hospitalised elderly patients aged 65 years and over: a prospective observational cohort study. Age Ageing. 2005, 34:75-7. 10.1093\/ageing\/afh234","journal-title":"Age Ageing"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228877-the-potential-role-of-angiotensin-converting-enzyme-inhibitors-and-beta-blockers-in-reducing-pneumonia-severity-in-older-adults","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T16:27:59Z","timestamp":1712075279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228877-the-potential-role-of-angiotensin-converting-enzyme-inhibitors-and-beta-blockers-in-reducing-pneumonia-severity-in-older-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.57463","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}